Similar articles for PMID: 17348460

Year	Number of Results
1968	1
1981	1
1982	2
1983	3
1984	1
1985	7
1986	4
1987	1
1988	2
1989	5
1990	5
1991	4
1992	6
1993	6
1994	4
1995	4
1996	14
1997	13
1998	11
1999	5
2000	25
2001	10
2002	6
2003	13
2004	21
2005	18
2006	27
2007	33
2008	19
2009	10
2010	7
2012	4
2013	2
2014	6
2015	1
2016	2
2017	3
2018	2
2019	1
2024	0

1

A phase III randomized study comparing paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with advanced ovarian cancer.

Mouratidou D, Gennatas C, Michalaki V, Papadimitriou A, Andreadis CH, Sykiotis C, Tsavaris N. Mouratidou D, et al. Anticancer Res. 2007 Jan-Feb;27(1B):681-5. Anticancer Res. 2007. PMID: 17348460 Free article. Clinical Trial.

2

[Clinical study of topotecan and cisplatin as first line chemotherapy in epithelial ovarian cancer].

Meng LH, Kong BH, Zhang YZ, Yang XS, Wang LJ, Su SL, Jiang J, Cui BX, Wang B. Meng LH, et al. Zhonghua Fu Chan Ke Za Zhi. 2007 Oct;42(10):683-7. Zhonghua Fu Chan Ke Za Zhi. 2007. PMID: 18241544 Clinical Trial. Chinese.

3

[Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation].

Gao KF, Liu FY, Chen FJ, Feng YL. Gao KF, et al. Ai Zheng. 2007 Apr;26(4):431-4. Ai Zheng. 2007. PMID: 17430668 Free article. Clinical Trial. Chinese.

4

Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.

Skarlos DV, Aravantinos G, Kosmidis P, Athanassiadis A, Stathopoulos GP, Pavlidis N, Bafaloukos D, Karphathios S, Papakostas P, Bamia C, Fountzilas G. Skarlos DV, et al. Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-57-S15-61. Semin Oncol. 1997. PMID: 9346224 Clinical Trial.

5

Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group).

McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M. McGuire WP, et al. Semin Oncol. 1996 Oct;23(5 Suppl 12):40-7. Semin Oncol. 1996. PMID: 8941409 Clinical Trial.

6

ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.

Harper P. Harper P. Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-23-S15-25. Semin Oncol. 1997. PMID: 9346217 Clinical Trial.

7

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.

McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M. McGuire WP, et al. N Engl J Med. 1996 Jan 4;334(1):1-6. doi: 10.1056/NEJM199601043340101. N Engl J Med. 1996. PMID: 7494563 Free article. Clinical Trial.

8

[Clinical study of comparison of CAF regimen and TP regimen in treatment of advanced breast cancer].

Lin XG, Xie DR, Yao HR, Li ZH, Jiang ZM, Liu TH. Lin XG, et al. Ai Zheng. 2003 Apr;22(4):411-4. Ai Zheng. 2003. PMID: 12704001 Clinical Trial. Chinese.

9

Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.

Wadler S, Yeap B, Vogl S, Carbone P. Wadler S, et al. Cancer. 1996 Feb 15;77(4):733-42. Cancer. 1996. PMID: 8616766 Clinical Trial.

10

[Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].

Zhao XD, Zhang Q, Zhang Y. Zhao XD, et al. Ai Zheng. 2005 Aug;24(8):1002-5. Ai Zheng. 2005. PMID: 16086882 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

299 results

Results by year